Apollo Endosurgery: Funding, Investors & Team (Sep 2026)
Apollo Endosurgery was founded upon the initial work of the Apollo Group, an international think tank of world-renowned gastroenterologists and surgeons from five leading universities (Mayo Clinic, Johns Hopkins, Medical University of South Carolina, University of Texas Medical Branch-Galveston and Chinese University-Hong Kong.) Disappointed with the pace of innovation in therapeutic flexible endoscopy, the Group assembled in 1998 (Timeline) with the goal to advance the new discipline; their specific focus was the use of long, flexible instruments deployed through a natural orifice in order to diagnose and potentially treat gastrointestinal disorders.
Apollo Endosurgery has raised $65.0M across 1 funding round on record, the most recent a Post-IPO Equity of $65.0M announced in Oct 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Apollo Endosurgery Company Profile and Key Stats
Latest funding round on record: Oct 2021.
Apollo Endosurgery Funding Rounds
Apollo Endosurgery Founders and Leadership Team
No contact details are on record for this team yet.
Apollo Endosurgery Funding Compared to Other Biotechnology Startups
Apollo Endosurgery's latest round of $65.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Apollo Endosurgery in Biotechnology and Austin
Companies Similar to Apollo Endosurgery
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Apollo Endosurgery Funding FAQs
What does Apollo Endosurgery do?
Apollo Endosurgery was founded upon the initial work of the Apollo Group, an international think tank of world-renowned gastroenterologists and surgeons from five leading universities (Mayo Clinic, Johns Hopkins, Medical University of South Carolina, University of Texas Medical Branch-Galveston and Chinese University-Hong Kong.) Disappointed with the pace of innovation in therapeutic flexible endoscopy, the Group assembled in 1998 (Timeline) with the goal to advance the new discipline; their specific focus was the use of long, flexible instruments deployed through a natural orifice in order to diagnose and potentially treat gastrointestinal disorders.
How much funding has Apollo Endosurgery raised?
Apollo Endosurgery has raised $65.0M across 1 round on record. The most recent is a Post-IPO Equity of $65.0M announced in Oct 2021.
When did Apollo Endosurgery last raise funding?
Apollo Endosurgery's most recent funding round on record is a Post-IPO Equity of $65.0M, announced in Oct 2021.
Who is the CEO of Apollo Endosurgery?
Chas McKhann is listed as CEO at Apollo Endosurgery.
Where is Apollo Endosurgery headquartered?
Apollo Endosurgery is based in Austin, Texas, United States.
How many employees does Apollo Endosurgery have?
Apollo Endosurgery is in the 101-250 employee band.
How does Apollo Endosurgery's funding compare to other Biotechnology startups?
Apollo Endosurgery's latest round of $65.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Apollo Endosurgery Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Apollo Endosurgery is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.